Can we count your visit with Google Analytics? No ads, no profiles. Details
VEEV
USHealth Care · Health Care Technology
Each weekday: the watchlist of pullbacks inside uptrends, every new ticker teardown, and the bubble shifts that move names like this one. Free. Education, not advice.
Free when you join: the $HOOD Teardown Dossier (Robinhood Markets), the full desk file we sell in the shop. One per new reader.
No spam. One email per day max, unsubscribe in one click. Pro ($49/mo) includes every dossier and report in the shop.
Structural: vertical cloud monopoly in life-sciences software - top 20 pharma all run Veeva for at least one mission-critical workflow; switching costs near-absolute once Vault holds clinical trial, regulatory submission and quality records of a multi-billion-dollar drug program.
Crossix (acquired 2019) added the patient-data leg, making Veeva the connective tissue between R&D, manufacturing and commercial in pharma.
(1) Vault CRM migration off $CRM Salesforce by 2030 expands TAM and recaptures the reseller margin; (2) AI agents layered on top of Vault data (clinical, quality, regulatory) are a natural monetization wedge with no comparable peer dataset; (3) ex-pharma verticalization (consumer products, chemicals via Vault Quality) extends the runway beyond the core life-sci customer; (4) FCF margin sustained above 40%, rule-of-50 profile; (5) net retention historically 110%+ on Vault.
(1) Salesforce divorce is a multi-year execution risk - pharma CRM migrations are slow and a botched cutover hands $CRM a re-entry; (2) GLP-1 era and biotech funding winter compress commercial-cloud seat growth at small/mid-biotech; (3) AI-native challengers (and pharma in-housing on $PLTR Foundry) could nibble at point workflows; (4) high-teens multiple of revenue prices in flawless Vault CRM landings; (5) FX and Europe pharma headwinds drag reported growth.
It reads our $VEEV data (thesis, key levels, peers, a year of prices) and any chart screenshot you paste, then explains the setup in plain English. Free with an email login, 5 questions a day. Education only: it never tells you to buy or sell, and it can be wrong, so check the numbers.
High-signal only
Auto-computed retracement of the trailing 52w low-high leg. Recomputed on each refresh; not a curated level.